Skip to content

Differences in serotonin synthesis between patients with major depression and healthy controls, measured with [11C]5-HTP PET

Differences in serotonin synthesis between patients with major depression and healthy controls, measured with [11C]5-HTP PET - Serotonin synthesis in depression

Status
Unknown
Phases
Unknown
Study type
Observational
Source
NL-OMON
Registry ID
NL-OMON39051
Enrollment
20
Registered
2012-06-25
Start date
Unknown
Completion date
Unknown
Last updated
2024-04-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Affective disorder Depression

Interventions

Patients: randomized treatment with a SSRI or CBT and 2 PET scans before and after 8 weeks of treatment + 1 MRI
healthy controls: 1 PET scan + 1 MRI.

Sponsors

Universitair Medisch Centrum Groningen
Lead Sponsor

Eligibility

Age
18 Years to 99 Years

Inclusion criteria

Inclusion criteria: Patients - Out-patients - Age 18-55. - Major depressive disorder, single or recurrent episode according to DSM IV. - Severity: >22 IDS-SR - No psychotic features - No intention to commit suicide, or a history of a seroious suicide attempt - No proven non-response to CBT during the current or a previous episode - No current or recent (1 month) and no current (

Exclusion criteria

Exclusion criteria: Similar for patients and healthy controls - Indication of medical/somatic illness that could interfere with study results or constitutes a risk factor when participating in the study and undergoing treatment. - Cardiovascular abnormalities that may be a risk factor when participating in the study. - Neurological damage or previous severe head injury - Consumption of chocolate, caffeinated products or tabacco within 24 hours of the scan. - Pregnancy or the intention to become pregnant during the estimated time course of the study. - Radiation exposure (for diagnostic reasons) as a radiological worker or during medical trial in the previous year. - Claustrophobia - Presence of materials in the body that can be magnetized, like: i. A pacemaker ii. Metal fragments iii. Shunts iv. Artificial heart valves v. Vascular clips vi. Fixed hearing aid vii. Tattoos containing metal viii. Hair implants ix. Artificial dentures

Design outcomes

Primary

MeasureTime frame
The primary parameter is the constant accumulation Kacc or Patlak rate (similar parameters resembling serotonin synthesis rate) in the brains, along with the scores on the IDS-SR. In addition, the k3, resembling AADC activity, will be measured. The difference (IDS-SR, Kacc, k3 or Patlak rate) between patients and healthy volunteers is shown as absolute values**. In addition, the Patlak Kacc and the scores on the IDS-SR correlated.

Secondary

MeasureTime frame
Secondary parameters are the ratio between tryptophan levels in plasma and other large amino acids and polymorphisms for several serotonin-related genes like the serotonin transporter, the 5-HT1A receptor, and tryptophan hydroxylase. In addition, the outcomes of the personality questionnaires are compared between the two groups and aspects like neuroticism and copings style are correlated to Kacc and Patlak rates. Also the outcome of the fMRI tasks and the MRS are related to Kacc and Patlak rates.

Countries

Netherlands

Outcome results

None listed

Source: NL-OMON (via WHO ICTRP)